A Dose-Escalation Study of Pegylated Liposomal Doxorubicin and Oxaliplatin in Patients with Advanced Solid Tumors

Publisher： Karger

E-ISSN： 1423-0232|71|3-4|190-196

ISSN： 0030-2414

Source： Oncology, Vol.71, Iss.3-4, 2007-07, pp. : 190-196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Dose-Escalation Study of Oxaliplatin and Vinorelbine in Patients with Advanced Solid Tumors

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 213-218

Karger

Access to resources Recommend Favorite

A Dose Escalation Study of Pegylated Liposomal Doxorubicin (Caelyx) in Combination with Capecitabine (Xeloda) in Patients with Refractory Solid Tumors

By  

Oncology, Vol. 69, Iss. 6, 2006-02 ,pp. : 463-469

Karger

Access to resources Recommend Favorite

Dose Escalation Study on Oxaliplatin and Capecitabine (Xeloda) in Patients with Advanced Solid Tumors

By  

Oncology, Vol. 66, Iss. 4, 2004-06 ,pp. : 253-259

Karger

Access to resources Recommend Favorite

A Dose Escalation Study of the Biweekly Administration of Paclitaxel, Oxaliplatin and Capecitabine in Patients with Advanced Solid Tumors

By  

Oncology, Vol. 72, Iss. 1-2, 2007-11 ,pp. : 45-50

Karger

Access to resources Recommend Favorite

Phase I Study of Paclitaxel (Taxol) and Pegylated Liposomal Doxorubicin (Caelyx) Administered Every 2 Weeks in Patients with Advanced Solid Tumors

By  

Oncology, Vol. 62, Iss. 3, 2002-06 ,pp. : 216-222

Karger

Access to resources Recommend Favorite